BioSpace News Archive

Sorrento Therapeutics, Inc. announced positive preliminary results from two Phase 2 studies designed to identify the hospitalized patient population suffering from COVID-19-induced pneumonia and respiratory depression likely to respond to treatment with oral Abivertinib.

Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the third quarter of fiscal 2021 (“Q3'21”).

Orthofix Medical Inc., a global medical device company with a spine and orthopedics focus, announced that it plans to release financial results for the third quarter 2021 before market open on Friday, November 5, 2021.

Hologic, Inc. announced that its Aptima® SARS-CoV-2/Flu Assay is now available for the simultaneous detection and differentiation of three respiratory viruses that can present with overlapping clinical symptoms.

Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that third quarter of fiscal year 2021 financial results will be released before the market opens on Tuesday, November 9, 2021.

Edwards Lifesciences reported financial results for the quarter ended September 30, 2021.

Invacare CorporationInvacare Corporation reported results for the quarter ended September 30, 2021.

The Board of Directors of PerkinElmer, Inc., declared a regular quarterly dividend of $0.07 per share of common stock October 27, 2021.

Brickell Biotech, Inc. announced today that it has commenced a proposed underwritten public offering of shares of its common stock.

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter 2021 on Wednesday, November 3, 2021 , after the market closes.